Read the latest press releases for 4D pharma plc.
Click on a news title to read full details. For Regulatory News Service (RNS) announcements please click here.
17 May 2022, 07:00
4D pharma announces the presentation of a late-breaking poster on data from Part A of the Phase I/II…
23 Mar 2022, 07:00
Primary Efficacy Endpoint Met Early in Renal Cell Carcinoma Group in Part B of Study. Company to…
22 Feb 2022, 07:00
4D pharma today announces US FDA clearance of its IND applications for Live Biotherapeutics MRx0005…
27 Jan 2022, 07:00
Part A of the Phase I/II clinical trial achieved the primary endpoint of safety and tolerability.…
3 Jan 2022, 12:00
4D pharma plc announces the appointment of John Doyle as Chief Financial Officer (CFO). Mr. Doyle…
13 Dec 2021, 07:00
Part A of the study meets primary endpoint of safety and tolerability
MRx-4DP0004 also achieved…
9 Dec 2021, 07:00
Results demonstrate changes in gut microbiome structure following administration of Blautix in both…
2 Aug 2021, 07:00
4D pharma announces two poster presentations at the European Society for Medical Oncology (ESMO)…
29 Jul 2021, 07:00
4D pharma announces the closing of a senior secured credit facility for up to $30m with Oxford…
26 Jul 2021, 13:00
4D pharma announces with great sadness the passing of John Beck, Chief Financial Officer of 4D…
6 Jul 2021, 07:00
4D pharma (AIM: DDDD, NASDAQ: LBPS) announces the publication of pre-clinical research relating to…
29 Jun 2021, 07:00
4D pharma (AIM: DDDD, NASDAQ: LBPS) management will present a corporate overview followed by a…
22 Jun 2021, 07:00
Christophe Carite, Director CMC & Development, 4D pharma plc (NASDAQ: LBPS, AIM: DDDD), will deliver…
4 Jun 2021, 07:00
4D pharma completes target enrollment of 30 patients for Part A of its Phase I/II clinical trial of…
